loading...| Preferred Name | calcipotriene | |
| Synonyms |
Psorcutan Daivonex calcipotriol heximar win care MC-903 1,24(OH)2-22-ene-24-cyclopropyl D3 9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-, (1alpha,3beta,5Z,7E,22E)- MC903 Sorilux MC 903 PRI-2205 Dovonex |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C055085 |
|
| altLabel |
Psorcutan Daivonex calcipotriol heximar win care MC-903 1,24(OH)2-22-ene-24-cyclopropyl D3 9,10-Secochola-5,7,10(19),22-tetraene-1,3,24-triol, 24-cyclopropyl-, (1alpha,3beta,5Z,7E,22E)- MC903 Sorilux MC 903 PRI-2205 Dovonex |
|
| cui |
C4045584 C0208763 C0720029 C1529665 C0065767 C3852796 C2940225 |
|
| Has mapping qualifier | ||
| HM |
D002117/Q000031 |
|
| II |
D000970 |
|
| Inverse of RB |
143NQ3779B |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
19880406 |
|
| MeSH Frequency |
1100 |
|
| MMR |
20230224 |
|
| notation |
C055085 |
|
| PA |
D003879 |
|
| prefLabel |
calcipotriene |
|
| RR |
112965-21-6 |
|
| SC |
1 |
|
| Scope Statement |
a topical dermatologic for the treatment of moderate plaque psoriasis; structure in first source |
|
| SRC |
Biochem Pharmacol 1988;37(5):889 |
|
| TERMUI |
T185263 T185264 T185265 T834026 T185266 T185267 T001133294 T859235 T622358 T185261 T185262 T000874962 |
|
| TH |
US MX UK NL NLM (2023) CA NLM (2015) USAN (1992) ES USAN (19XX) INN (19XX) NLM (2013) DE AU FDA SRS (2015) NLM (1988) NLM (2014) FR IE |
|
| tui |
T109 T121 |